BP
GILD icon

BNP Paribas’s Gilead Sciences GILD Stock Holding History

BNP Paribas’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Buy
98,342
+5,789
+6% +$811K 0.44% 48
2025
Q4 		$11.4M Buy
92,553
+23,078
+33% +$2.8M 0.33% 57
2025
Q3 		$7.71M Sell
69,475
-16,020
-19% -$1.82M 0.23% 72
2025
Q2 		$9.47M Buy
85,495
+150
+0.2% +$16K 0.31% 64
2025
Q1 		$9.56M Buy
85,345
+10,946
+15% +$1.13M 0.4% 64
2024
Q4 		$6.87M Sell
74,399
-2,996
-4% -$270K 0.04% 75
2024
Q3 		$6.49M Sell
77,395
-4,020
-5% -$307K 0.27% 63
2024
Q2 		$5.58M Buy
81,415
+2,810
+4% +$188K 0.28% 64
2024
Q1 		$5.76M Buy
+78,605
New +$6.04M 0.27% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BNP Paribas's GILD Position: Q1 2026 in Review

BNP Paribas increased its Gilead Sciences (GILD) stake by 6.3% in Q1 2026, buying an estimated $811K and bringing the position to 98,342 shares worth $13.7M. The position accounts for 0.44% of the portfolio, ranked #48.

BNP Paribas first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • BNP Paribas held 98,342 shares of Gilead Sciences worth $13.7M as of Q1 2026.
  • BNP Paribas bought 5,789 Gilead Sciences shares in Q1 2026, an estimated $811K.
  • Gilead Sciences made up 0.44% of BNP Paribas's portfolio in Q1 2026, its #48 holding.
  • BNP Paribas first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.